MedPath

Treatment of dysmenorrhoea with hingvadi churna vati and dashmultrivritadi basti

Not yet recruiting
Conditions
Dysmenorrhea, unspecified,
Registration Number
CTRI/2021/04/033096
Lead Sponsor
RGGPG Ayurvedic College and Hospital
Brief Summary

Patients will  be selected from opd and ipd of RGGPG Ayu.College and Hospital,Paprola.

Two groups of 15patients each,will be registered and one group will be given Hingwadi churna vati orally and in other group,Dashmooltrivrit yoga basti will be adminstered.Assessment of the effect of treatment will be done on the basis of subjective and objective signs and symptoms of krichhrartava w.s.r.to dysmenorrhoea on the basis of grading and scoring system.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
30
Inclusion Criteria

1.patient willing for the trial 2.patient between the age group of 16-45 years 3.patients coming with chief complaint of krichhartva during mensturation.

Exclusion Criteria
  • Patient not willing for trial 2.patient with uterine and pelvic pathology like big fibriod > 5 cm ,endocervical polyp,CA cervix etc.
  • Patient suffering from maligancy and other chronic and systemic disorders specially those that are mention as ashadhaya vayadi as per clinical text of ayurveda will be exculded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Relief in the symptoms of Dysmenorrohea3 months during the treatment period and at follow up of 1 month
Secondary Outcome Measures
NameTimeMethod
Painless menstruation and feeling of gernal wellbeingPainless menstruation after 3 monthsof trial

Trial Locations

Locations (1)

Rggpg Ayurvedic College,Paprola

🇮🇳

Kangra, HIMACHAL PRADESH, India

Rggpg Ayurvedic College,Paprola
🇮🇳Kangra, HIMACHAL PRADESH, India
Neha Rani
Principal investigator
8894356189
nehaprashar51@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.